Overview
Lobbying Costs
150,000€
Financial year: Jan 2017 - Dec 2017
Lobbyists (Full time equivalent)
1 Fte (4)
Lobbyists with EP accreditation
0
High-level Commission meetings
1
Lobbying Costs over the years
-
Info
The Health Policy Partnership (HPP)
EU Transparency Register
223430420230-66 First registered on 08 Jan 2016
Goals / Remit
We are a specialist health policy consultancy.
We create innovative policy initiatives and powerful evidence–based communications for organisations across the health spectrum. We provide a unique, seamless approach to help resolve the most complex issues facing our health care systems.
We do this through rigorous research and expert synthesis of evidence, inter-sectoral collaboration, and powerful communications that act as the starting point for meaningful changes in policy and practice.Main EU files targeted
We worked closely with many of the MEPs who initiated Written Declaration 110/2016 on Heart Failure (Oct'16 - Jan '17), providing support to a broader public campaign over that period to raise awareness of the Declaration to all MEPs and to other supporters (e.g. NGOs) across Europe.
Beyond WD 110/2016, we work with several MEPs who have donated their time for free to support (and act as Members of) the Heart Failure Policy Network (HFPN). For more details of the Network's history and activities in 2017 please see www.hfpolicynetwork.eu.
HPP is a member of the The EU Health Policy Platform (representing the HFPN). See: https://ec.europa.eu/health/interest_groups/policy_platform_enAddress
Head Office
The Health Policy Partnership
68-69 St Martin's Lane
London WC2N 4JS
UNITED KINGDOM -
People
Total lobbyists declared
4
Employment time Lobbyists 25% 4 Lobbyists (Full time equivalent)
1
Lobbyists with EP accreditation
No lobbyists with EP accreditations
Complementary Information
Time provided above relates to HPP staff time dedicated to any formal engagement with MEPs, EU officials, or where there is policy activity directly involving or targeting EU institutions - i.e. it excludes general health policy activities where other audiences are our primary targets (e.g. national policy makers, academic experts, clinicians, health providers etc), and global activities.
Person in charge of EU relations
Mr Edward Harding (Managing Director)
Person with legal responsibility
Mr Harding Ed (Managing Director)
-
Categories
Category
I - Professional consultancies/law firms/self-employed consultants
Subcategory
Professional consultancies
-
Networking
Affiliation
Heart Failure Policy Network - www.hfpolicynetwork.eu
(provide secretariat and lead project)
Knowledge partner for European Cancer Patients Coalition (www.ecpc.org) and the Coalition to Eradicate Viral Hepatitis from Asia Pacific (www.cevhap.org)
Expert member of the European Institute for Women's Health (www.eurohealth.ie)Member organisations
Please see www.hfpolicynetwork.eu
-
Financial Data
Closed financial year
Jan 2017 - Dec 2017
Lobbying costs for closed financial year
150,000€
Other financial info
Some of the funding declared above was received as consultancy fees.
Funding for the role of the Health Policy Partnership as secretariat for the Heart Failure Policy Network was in the form of a grant from Novartis Pharma and St Jude Medical.Declared lobby clients
Client Name Amount Amgen 10,000€ - 24,999€ Bristol Myers Squibb 10,000€ - 24,999€ ELI LILLY 10,000€ - 24,999€ European Cancer Patients Coalition 10,000€ - 24,999€ MSD 10,000€ - 24,999€ Novartis Pharma AG 50,000€ - 99,999€ -
EU Structures
Groups (European Commission)
none
Groups (European Parliament)
None
Communication activities
1) HF POLICY NETWORK
HPP acts as Secretariat for the HF Policy Network, a multidisciplinary group of politicians from across Europe working with patients, health professionals and other stakeholders to lead significant policy changes that may improve the lives of people with heart failure (HF).
Past the close of WD 110/2017, further engagement with the EP / EU institutions in 2017 is in our mission statement, and is under discussion with members. The exact format and scope of any such plans will confirmed here in the Register as soon as plans are formalised.
2) ALL.CAN
We provide secretariat for a multistakeholder initiative, All.Can, aiming to improve the efficiency of cancer care. This involves at least one MEP and a number of European-level organisations, and an event took place in December 2016 in the European Parliament (hosted by MEPs) to launch the policy report for the group.
3) SARCOMA EXPERT GROUP
We coordinated an expert group on sarcoma which involves an MEP, who hosted the launch of the policy report for the group in February 2017.Other activities
For clarity we mention here previous (i.e. lapsed) projects or parallel workstreams in the health policy sphere that are of note, and/or do not involve any formal engagement or activity with EU institutions.
1. Development of the Immuno-Oncology Action Framework with the Expert Group on Immuno-Oncology, in partnership with the European Cancer Patients Coalition, with MEP involvement - see www.healthpolicypartnership.com/io
2. Collaboration with European Cancer Patients Coalition to build an information portal on cancer immunotherapy - http://iop.ecpc.org/
3. International environmental scan on person-centred care, in partnership with the Health Foundation - http://www.healthpolicypartnership.com/example-work/person-centred-care/
4. Development of a European policy atlas on the prevention of AF-related stroke - www.healthpolicypartnership.com/af
5. Launch of a Policy Toolkit on Diabetes in partnership with International Diabetes Federation Europe - www.healthpolicypartnership.com/expand
6. Facilitation of policy workshops on viral hepatitis in partnership with the Coalition to Eradicate Viral Hepatitis from Asia Pacific (CEVHAP) as well as other hepatitis multistakeholder platforms, leading to several publications
7. Development of a policy checklist on sarcoma, working with a multi-disciplinary expert group (see www.healthpolicypartnership.com for more information)
8. Secretariat for a multi-sector platform looking at improving the efficiency of cancer care (All.Can - see www.healthpolicypartnership.com for more information)
9. Other publications and policy analysis on different health topics, see: www.healthpolicypartnership.com/publicationsMeetings
Meetings
1 meetings found. Download meetings
The list below covers meetings with Commissioners/Cabinet members/Directors-general (high-level) Commission meetings published December 2014 to December 2024, and the meetings of Commissioners/Cabinet members/Directors-general and officials holding "management functions" in the Commission published since 1 January 2025. Other lobby meetings with lower-level staff may well have taken place, but the Commission doesn't proactively publish information about these meetings. All information below comes from the Commission and not from the registrant.
1 July 2024: We have noted that some meetings are appearing in duplicate, ie. some meetings seem to be listed twice. This seems to be because the Commission changes some element of a meeting data after the meeting has first been listed, which causes LobbyFacts to register it as a new meeting. We are investigating further.
-
Date 25 Oct 2023 Location Brussels, Belgium Subject Role of the EU in promoting heart health Cabinet Cabinet of Commissioner Mairead Mcguinness Portfolio Financial services, financial stability and Capital Markets Union Attending - Katherine Power (Cabinet member)